Adiuvo Diagnostics
Adiuvo Diagnostics is a social enterprise focused on creating platform technologies in Opto-Electronics to assist in early disease detection, especially in low-resource settings. They have developed an innovative multispectral autofluorescence imaging device that leverages machine learning for quick, label-free diagnostics with applications ranging from pathogen detection to cancer diagnosis. The company is recognized for its innovation, has received awards, and collaborates with various partners and supporters.
Industries
Nr. of Employees
small (1-50)
Products
Handheld AI-enabled optical device for wound infection screening
A portable, handheld optical imaging device that captures autofluorescence spectral images and uses machine learning to provide rapid, label-free assessment of wound infections, including automated Gram-type classification and infection monitoring.
Portable photoluminescence detection platform (lanthanide assay)
A portable photoluminescence assay and detector configured for rapid, sensitive, and selective detection of europium and terbium as a demonstrator of portable assay chemistry and optics.
CRISPR-based nucleobase detection research prototype
A research-stage nucleobase detection method using FnCas9 applied to rapid pathogen (including SARS-CoV-2) detection, demonstrating integration of molecular assays with diagnostic workflows.
Handheld AI-enabled optical device for wound infection screening
A portable, handheld optical imaging device that captures autofluorescence spectral images and uses machine learning to provide rapid, label-free assessment of wound infections, including automated Gram-type classification and infection monitoring.
Portable photoluminescence detection platform (lanthanide assay)
A portable photoluminescence assay and detector configured for rapid, sensitive, and selective detection of europium and terbium as a demonstrator of portable assay chemistry and optics.
CRISPR-based nucleobase detection research prototype
A research-stage nucleobase detection method using FnCas9 applied to rapid pathogen (including SARS-CoV-2) detection, demonstrating integration of molecular assays with diagnostic workflows.
Services
Customized point-of-care platform development
Collaborative development and tailoring of optical-imaging and analysis platforms to address specific diagnostic applications and constraints encountered in low-resource and clinical settings.
Trials and evaluation partnerships for optical diagnostic devices
Partnerships to conduct clinical evaluations, pilot trials, and field testing of point-of-care optical imaging devices, including study design support and data collection for validation.
Product demonstrations and trial requests
Provision of device demonstrations and short-term trials to prospective clinical users within the stated market.
Customized point-of-care platform development
Collaborative development and tailoring of optical-imaging and analysis platforms to address specific diagnostic applications and constraints encountered in low-resource and clinical settings.
Trials and evaluation partnerships for optical diagnostic devices
Partnerships to conduct clinical evaluations, pilot trials, and field testing of point-of-care optical imaging devices, including study design support and data collection for validation.
Product demonstrations and trial requests
Provision of device demonstrations and short-term trials to prospective clinical users within the stated market.
Expertise Areas
- Optical diagnostics and autofluorescence imaging
- Point-of-care device development
- AI/ML for medical spectral image analysis
- Wound infection screening and monitoring
Key Technologies
- Multispectral autofluorescence imaging
- Autofluorescence lifetime spectroscopy
- Photoluminescence assays (portable detection)
- CRISPR-based nucleic acid detection (FnCas9)